2021年6月7日全球新冠肺炎疫情及疫苗接种简报:日新增31.3万,广东省疫苗接种提速,国内计划上半年完成40%人口完全免疫

2021-06-07 MedSci整理 MedSci整理

截至北京时间2021年6月7日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17402万例,新增312,823例,达到174,026,732

截至北京时间2021年6月7日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过17402万例,新增312,823例,达到174,026,732例。累计死亡病例374.2万例,达到3,742,939例。新增死亡为6,841例。康复为157,289,588例,重症和危重症病人达到87,418例;全球新冠确诊病例超过100万例的国家达28个,94个国家病例超10万例。昨日报道:2021年6月6日全球新冠肺炎疫情及疫苗接种简报:日新增39.0万,加拿大允许混合接种疫苗,至少60%人口接种一剂

印度单日新增确诊病例超13万例 一地区单月有近1万名儿童新冠阳性

据印度卫生部4日公布的最新数据,印度新冠肺炎确诊病例升至28574350例。在过去24小时内,印度新增确诊病例132364例;新增死亡病例2713例,累计死亡病例达340702例。

据“今日印度”电视台网站报道,今年5月,第二波新冠疫情席卷印度,来自马哈拉施特拉邦的一个地区近日报告了一项重要的统计数据:上个月,该邦的Ahmednagar地区有超过9900名儿童新冠病毒检测结果呈阳性。

4天千万剂次!总数破7000万!广东新冠疫苗接种再创新高

截至2021年6月6日18时,广东累计接种新冠病毒疫苗7123.76万剂次,累计接种5595.14万人,共有1543.48万人完成全程接种。

其中,18-59岁人群累计接种7082.95万剂次,累计接种5555.06万人;至少接种1剂目标人群覆盖率66.91%。

广东疫苗接种继续提速。累计接种量从6000万剂次到7000万剂次,广东仅用了4天。6月5日,广东单日接种量达280.27万剂次,创下新高。

广东16天新增感染者破百例,一村28人感染

从5月21日广东省出现第一例本土新冠患者,16天以来,广东新冠感染者人数日益增加。截至6月5日24时,广东全省报告确诊病例89例,无症状感染者25例,共报告114例感染者。其中超7成感染者为广州报告,确诊病例80,无症状感染者9例。

国家卫健委网站6月6日消息,6月5日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例30例,其中境外输入病例23例(上海7例,四川6例,广东2例,云南2例,北京1例,天津1例,江苏1例,浙江1例,福建1例,陕西1例),本土病例7例(均在广东);无新增死亡病例;新增疑似病例2例,均为境外输入病例(均在上海)。

中国21个新冠疫苗进入临床试验

国家卫健委副主任、国务院联防联控机制科研攻关组疫苗研发专班负责人曾益新6日接受新华社记者专访时表示,我国已有21个新冠疫苗进入临床试验阶段。目前有4个疫苗在国内获批附条件上市,3个疫苗在国内获批紧急使用,8个疫苗在国外获批开展Ⅲ期临床试验,1个mRNA疫苗在国外获伦理批准,实现了境外临床试验灭活疫苗、重组蛋白疫苗、腺病毒载体疫苗、核酸疫苗技术路线的全面覆盖。

2021年6月5日:31省份已累计报告接种新冠病毒疫苗76306.5万剂次,新增1858.2万剂次

截至2021年6月5日,31个省(自治区、直辖市)和新疆生产建设兵团累计报告接种新冠病毒疫苗76306.5万剂次。

上一日接种74448.3万剂次,新增1858.2万剂次。中国七日平均接种超过2000万剂次。

孟加拉国,尼泊尔等批准科兴疫苗紧急使用

孟加拉国药品管理总局6日批准中国北京科兴中维生物技术有限公司研发的新冠灭活疫苗“克尔来福”在孟紧急使用。

这是孟加拉国批准在该国紧急使用的第二款中国新冠疫苗。孟政府于4月底批准中国国药新冠疫苗在孟紧急使用,并于5月下旬首次组织当地民众接种中国国药新冠疫苗。

孟加拉国1月下旬启动新冠疫苗接种工作。据孟卫生部门公布的数据,截至目前该国已接种新冠疫苗约900万剂。除两款中国新冠疫苗外,孟加拉国还批准了俄罗斯“卫星V”等3种新冠疫苗在该国紧急使用。

据尼泊尔药品管理局发布的公告,“克尔来福”疫苗将用于为18岁及以上年龄人群接种。

包括“克尔来福”疫苗在内,尼泊尔已批准5款新冠疫苗在尼紧急使用,其他4款分别是在印度生产的阿斯利康疫苗、中国国药集团疫苗、印度研制的Covaxin疫苗和俄罗斯的“卫星V”疫苗。

在6月10日至30日间,新冠疫苗接种将优先安排第二针,上半年需要完成40%人口完成接种

广州疾控中心副主任张周斌称,待疫情得到控制,恢复大规模接种疫苗后,“安排接种第二剂次的市民优先预约”。

国家卫生健康委疾控局二级巡视员崔钢说道:“目前接种工作进展比较顺利,为了保证第二剂疫苗的接种,我们要求各地进一步细化接种计划,前期31个省(自治区、直辖市)和新疆生产建设兵团都派驻了工作组,精准测算不同剂次的需求,合理安排第二剂次接种,确保第二剂接种的需求。”

以色列60%人口完成两针接种

美国病例新增已达去年3月份水平

以色列虽然开放,最近1个月疫情仅零星偶发

阿联酋疫情反弹,但是死亡人数仍然维持在个位数,可能是疫苗的保护作用

目前阿联酋有超过60%人口接种过疫苗,但是疫情仍然在反弹。不过死亡率很低,一直维持在个位数。粗死亡率在0.2%左右,可能与疫苗保护有关。

此前已大规模使用中国国药中生新冠疫苗的阿联酋与巴林宣布,将为接种疫苗至少6个月的民众提供国药疫苗的加强针,并优先考虑老年人和患有慢性病的弱势群体。

全球新冠疫苗接种超过21亿剂次

Country
Cumulative COVID-19 vaccinations doses
World 2.12 billion
Asia 1.19 billion
Upper middle income 1.03 billion
High income 777.58 million
China 763.07 million
Europe 383.36 million
North America 375.45 million
Lower middle income 303.84 million
United States 300.27 million
European Union 267.52 million
India 225.57 million
South America 128.84 million
Brazil 71.43 million
United Kingdom Jun 4, 2021 67.28 million
England Jun 4, 2021 56.60 million
Germany Jun 4, 2021 54.24 million
France Jun 4, 2021 39.57 million
Italy 37.67 million
Africa 34.85 million
Mexico Jun 4, 2021 34.46 million
Russia 30.61 million
Turkey 30.58 million
Spain Jun 3, 2021 28.75 million
Indonesia 28.70 million
Canada 25.77 million
Poland 22.03 million
Chile Jun 4, 2021 19.42 million
Japan Jun 3, 2021 15.61 million
Morocco 15.01 million
Saudi Arabia 14.84 million
Argentina 13.73 million
United Arab Emirates 13.29 million
Colombia 11.49 million
Israel 10.59 million
Bangladesh 10.02 million

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1900144, encodeId=6cc51900144cf, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Wed Mar 30 19:48:39 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258016, encodeId=fe73125801638, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Jun 08 21:48:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971509, encodeId=a5cc9e15096e, content=广州感染源到底是啥= =, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/39b2f26c5472459e839fa31189c395a6/b238455e266740099133e1d136de1ff4.png, createdBy=b77a5416288, createdName=天天黑眼圈, createdTime=Mon Jun 07 13:23:01 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029569, encodeId=ee271029569b7, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jun 07 09:48:39 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971461, encodeId=d6ba9e146123, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7d75515065, createdName=ELVA XING, createdTime=Mon Jun 07 09:33:36 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971445, encodeId=77139e1445f4, content=Great!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jun 07 09:16:20 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971440, encodeId=bafe9e14404f, content=疫情防控常态化, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Mon Jun 07 08:52:52 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2022-03-30 3631173
  2. [GetPortalCommentsPageByObjectIdResponse(id=1900144, encodeId=6cc51900144cf, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Wed Mar 30 19:48:39 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258016, encodeId=fe73125801638, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Jun 08 21:48:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971509, encodeId=a5cc9e15096e, content=广州感染源到底是啥= =, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/39b2f26c5472459e839fa31189c395a6/b238455e266740099133e1d136de1ff4.png, createdBy=b77a5416288, createdName=天天黑眼圈, createdTime=Mon Jun 07 13:23:01 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029569, encodeId=ee271029569b7, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jun 07 09:48:39 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971461, encodeId=d6ba9e146123, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7d75515065, createdName=ELVA XING, createdTime=Mon Jun 07 09:33:36 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971445, encodeId=77139e1445f4, content=Great!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jun 07 09:16:20 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971440, encodeId=bafe9e14404f, content=疫情防控常态化, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Mon Jun 07 08:52:52 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1900144, encodeId=6cc51900144cf, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Wed Mar 30 19:48:39 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258016, encodeId=fe73125801638, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Jun 08 21:48:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971509, encodeId=a5cc9e15096e, content=广州感染源到底是啥= =, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/39b2f26c5472459e839fa31189c395a6/b238455e266740099133e1d136de1ff4.png, createdBy=b77a5416288, createdName=天天黑眼圈, createdTime=Mon Jun 07 13:23:01 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029569, encodeId=ee271029569b7, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jun 07 09:48:39 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971461, encodeId=d6ba9e146123, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7d75515065, createdName=ELVA XING, createdTime=Mon Jun 07 09:33:36 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971445, encodeId=77139e1445f4, content=Great!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jun 07 09:16:20 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971440, encodeId=bafe9e14404f, content=疫情防控常态化, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Mon Jun 07 08:52:52 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2021-06-07 天天黑眼圈

    广州感染源到底是啥= =

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1900144, encodeId=6cc51900144cf, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Wed Mar 30 19:48:39 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258016, encodeId=fe73125801638, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Jun 08 21:48:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971509, encodeId=a5cc9e15096e, content=广州感染源到底是啥= =, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/39b2f26c5472459e839fa31189c395a6/b238455e266740099133e1d136de1ff4.png, createdBy=b77a5416288, createdName=天天黑眼圈, createdTime=Mon Jun 07 13:23:01 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029569, encodeId=ee271029569b7, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jun 07 09:48:39 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971461, encodeId=d6ba9e146123, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7d75515065, createdName=ELVA XING, createdTime=Mon Jun 07 09:33:36 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971445, encodeId=77139e1445f4, content=Great!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jun 07 09:16:20 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971440, encodeId=bafe9e14404f, content=疫情防控常态化, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Mon Jun 07 08:52:52 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2021-06-07 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1900144, encodeId=6cc51900144cf, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Wed Mar 30 19:48:39 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258016, encodeId=fe73125801638, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Jun 08 21:48:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971509, encodeId=a5cc9e15096e, content=广州感染源到底是啥= =, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/39b2f26c5472459e839fa31189c395a6/b238455e266740099133e1d136de1ff4.png, createdBy=b77a5416288, createdName=天天黑眼圈, createdTime=Mon Jun 07 13:23:01 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029569, encodeId=ee271029569b7, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jun 07 09:48:39 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971461, encodeId=d6ba9e146123, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7d75515065, createdName=ELVA XING, createdTime=Mon Jun 07 09:33:36 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971445, encodeId=77139e1445f4, content=Great!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jun 07 09:16:20 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971440, encodeId=bafe9e14404f, content=疫情防控常态化, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Mon Jun 07 08:52:52 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2021-06-07 ELVA XING

    不错

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1900144, encodeId=6cc51900144cf, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Wed Mar 30 19:48:39 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258016, encodeId=fe73125801638, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Jun 08 21:48:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971509, encodeId=a5cc9e15096e, content=广州感染源到底是啥= =, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/39b2f26c5472459e839fa31189c395a6/b238455e266740099133e1d136de1ff4.png, createdBy=b77a5416288, createdName=天天黑眼圈, createdTime=Mon Jun 07 13:23:01 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029569, encodeId=ee271029569b7, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jun 07 09:48:39 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971461, encodeId=d6ba9e146123, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7d75515065, createdName=ELVA XING, createdTime=Mon Jun 07 09:33:36 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971445, encodeId=77139e1445f4, content=Great!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jun 07 09:16:20 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971440, encodeId=bafe9e14404f, content=疫情防控常态化, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Mon Jun 07 08:52:52 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2021-06-07 weigq

    Great!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1900144, encodeId=6cc51900144cf, content=<a href='/topic/show?id=70674912438' target=_blank style='color:#2F92EE;'>#广东省#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49124, encryptionId=70674912438, topicName=广东省)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7a159, createdName=3631173, createdTime=Wed Mar 30 19:48:39 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258016, encodeId=fe73125801638, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Tue Jun 08 21:48:39 CST 2021, time=2021-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971509, encodeId=a5cc9e15096e, content=广州感染源到底是啥= =, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220712/39b2f26c5472459e839fa31189c395a6/b238455e266740099133e1d136de1ff4.png, createdBy=b77a5416288, createdName=天天黑眼圈, createdTime=Mon Jun 07 13:23:01 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029569, encodeId=ee271029569b7, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Mon Jun 07 09:48:39 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971461, encodeId=d6ba9e146123, content=不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7d75515065, createdName=ELVA XING, createdTime=Mon Jun 07 09:33:36 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971445, encodeId=77139e1445f4, content=Great!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Mon Jun 07 09:16:20 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971440, encodeId=bafe9e14404f, content=疫情防控常态化, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqmnwwP0IZtBy0VryVT8gMMm1jO22jvqt2Xs4LDJR8j1KJIjfNWQaxQc8Ha3l07yNnXOkbQcO9dM/0, createdBy=2b572011268, createdName=杨群, createdTime=Mon Jun 07 08:52:52 CST 2021, time=2021-06-07, status=1, ipAttribution=)]
    2021-06-07 杨群

    疫情防控常态化

    0

相关资讯

2021年6月3日全球新冠肺炎疫情及疫苗接种简报:日新增46.7万,以色列为儿童接种新冠疫苗,再领先一步

截至北京时间2021年6月3日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17238万例,新增467,466例,达到172,384,887

科兴新冠疫苗列入世卫紧急使用清单,全球供应已超6亿剂

当地时间6月1日,世卫组织(WHO)宣布,北京科兴中维生物技术有限公司研制的新冠灭活疫苗通过了评审,正式列入“紧急使用清单”(EUL)。

2021年6月5日全球新冠肺炎疫情及疫苗接种简报:日新增39.7万,疫情下奥运会将如期举行

截至北京时间2021年6月5日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17329万例,新增397,818例,达到173,292,544

2021年6月4日全球新冠肺炎疫情及疫苗接种简报:日新增45.6万,全球新冠疫苗接种超20亿剂次,康复人数超过持续超过新增病例数,疫情持续好转

截至北京时间2021年6月4日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17287万例,新增456,392例,达到172,873,286

2021年6月2日全球新冠肺炎疫情及疫苗接种简报:日新增42.8万,科兴新冠疫苗列入世卫紧急使用清单

截至北京时间2021年6月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17189万例,新增428,482例,达到171,895,056

2021年6月6日全球新冠肺炎疫情及疫苗接种简报:日新增39.0万,加拿大允许混合接种疫苗,至少60%人口接种一剂

截至北京时间2021年6月6日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17370万例,新增390,231例,达到173,702,713